Filing excerpt
As a result of the CareFusion acquisition, our U.S. infusion pump business is operating under a Consent Decree with the FDA.
The company's U.S. infusion pump business is operating under an FDA Consent Decree, forcing a large-scale replacement and return-to-market for its BD Alaris™ Infusion Systems.
Filing excerpt
As a result of the CareFusion acquisition, our U.S. infusion pump business is operating under a Consent Decree with the FDA.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qproductLaunchGet every 10-Q signal for BD and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at BD this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/d4116f3a-104d-4222-9bdf-a4171b1f378f returns this record as JSON. POST /v1/companies/enrich returns every signal for bd.com.
{
"signal_id": "d4116f3a-104d-4222-9bdf-a4171b1f378f",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-08-11T08:11:19.804+00:00",
"company": {
"name": "BD",
"domain": "bd.com"
},
"data": {
"detail": "The company's U.S. infusion pump business is operating under an FDA Consent Decree, forcing a large-scale replacement and return-to-market for its BD Alaris™ Infusion Systems. This creates urgent needs for solutions in supply chain logistics, compliance tracking, customer readiness management, and regulatory reporting to mitigate significant financial and legal risks.",
"metrics": {
"timeframe": "current_year"
},
"summary": "BDX manages large-scale replacement of Alaris Infusion Systems under FDA Consent Decree.",
"excerpts": "As a result of the CareFusion acquisition, our U.S. infusion pump business is operating under a Consent Decree with the FDA.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/10795/000001079526000035/bdx-20260630.htm",
"filing_date": "2026-08-06",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/d4116f3a-104d-4222-9bdf-a4171b1f378f \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bd.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.